VP, Portfolio & Decision Analysis, Pfizer
Joanna Wolkowski is Vice President at Pfizer and Lead of Portfolio & Decision Analysis (PDA). Her group is responsible for driving rigorous analyses and generating competitive insights to enable R&D investment decisions which maximize pipeline value and enable Pfizer’s long-term strategy. In addition to building and maintaining robust economic valuations for 100+ R&D projects, PDA oversees overall portfolio health and sustainability for Pfizer’s senior-most leaders.
Formerly, Joanna was a Principal at the Boston Consulting Group in the firm’s Health Care Practice Area. Her experience focused on corporate and commercial strategy within the pharmaceutical industry, driving strategic recommendations across therapeutic areas at the highest levels of client organizations. Earlier in her career, Joanna worked for six years with Pfizer as a Discovery Chemist, Pharmaceutical Sales Representative, and Associate within the Strategic Management Group. She also worked with Sierra Nevada Brewing Company in their Sales and Marketing Division.
Joanna earned a BA in Chemistry from Middlebury College, an MS in Chemistry from Yale University, and an MBA in Health Care Management and Strategic Management from the Wharton School of the University of Pennsylvania. In addition to being a sports enthusiast and avid runner, golfer, and skier, she enjoys boating and brewing her own beer.
Pharmaceutical drug investment decisions rely heavily on data and data analytics to inform executive-level decision-making. Recently, there is a focus on exploring new products and services in the digital arena in the hopes of unlocking value and improving decision quality. The intent of machine learning and artificial intelligence is to translate relevant data and information […]